Regardless of the presence of central or noncentral obesity, the PCOS group, compared to the control group, generally had significantly increased LH, LH/FSH, total testosterone, and androstenedione levels, but had no significant differences in the levels of TSH, PRL, FSH, and E2 (Figure 2). The gene discussed is BRD2; the disease is obesity disorder.